Nuvion visilizumab: Phase I/II interim data

Thirty-day interim data from an international Phase I/II trial in 50

Read the full 112 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE